Gilead: Your Biggest Consideration
The EBITDA to EV ratio has been growing for two straight years, nearly doubling from 44% to 72%, showing increasing momentum in the company. Late last month, I exited my long position on Gilead .
from Biotech News
The EBITDA to EV ratio has been growing for two straight years, nearly doubling from 44% to 72%, showing increasing momentum in the company. Late last month, I exited my long position on Gilead .
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments